JW Shinyak Corp. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
70,695
73,018
76,945
83,385
76,843
Cost of Goods Sold (COGS) incl. D&A
35,192
33,910
34,188
37,830
40,076
Gross Income
35,502
39,108
42,757
45,554
36,767
SG&A Expense
32,439
34,711
36,276
38,272
39,226
EBIT
2,382
3,745
5,849
6,682
3,167
Unusual Expense
109
-
1,612
14
1,452
Non Operating Income/Expense
606
291
809
69
500
Interest Expense
3,017
3,917
4,140
6,156
2,345
Pretax Income
127
423
1,378
1,056
6,275
Income Tax
2,963
975
1,152
1,555
191
Consolidated Net Income
3,090
553
227
499
6,084
Net Income
3,068
527
256
482
6,079
Net Income After Extraordinaries
3,068
527
256
482
6,079
Net Income Available to Common
3,068
527
256
482
6,079
EPS (Basic)
81.00
14.00
7.00
12.00
154.00
Basic Shares Outstanding
38
39
39
39
39
EPS (Diluted)
81.41
13.58
6.59
12.41
154.39
Diluted Shares Outstanding
38
39
39
39
39
EBITDA
5,039
6,421
8,581
8,723
991
Other Operating Expense
681
651
632
600
708
Non-Operating Interest Income
10
303
472
447
190
Minority Interest Expense
22
26
29
17
5

About JW Shinyak

View Profile
Address
2477 Nambusunhwan-ro
Seoul SL 06725
Korea, Republic Of
Employees -
Website http://www.jw-shinyak.co.kr
Updated 09/14/2018
JW SHINYAK Corp. engages in the manufacture and sale of pharmaceutical products. Its products include hair solvent, steroid hormone, antibiotics, integument solvent, medicines of sense organ, and antifungals. The company was founded in 1975 and is headquartered in Seoul, South Korea.